Imaging, Diagnosis, Prognosis
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Torsten O. Nielsen, Joel S. Parker, Samuel Leung, David Voduc, Mark Ebbert, Tammi Vickery, Sherri R. Davies, Jacqueline Snider, Inge J. Stijleman, Jerry Reed, Maggie C.U. Cheang, Elaine R. Mardis, Charles M. Perou, Philip S. Bernard and Matthew J. Ellis
Torsten O. Nielsen
Joel S. Parker
Samuel Leung
David Voduc
Mark Ebbert
Tammi Vickery
Sherri R. Davies
Jacqueline Snider
Inge J. Stijleman
Maggie C.U. Cheang
Elaine R. Mardis
Charles M. Perou
Philip S. Bernard
Matthew J. Ellis
DOI: 10.1158/1078-0432.CCR-10-1282 Published November 2010
Volume 16, Issue 21, pp. 5222-5232
https://doi.org/10.1158/1078-0432.CCR-10-1282
Received May 13, 2010
Revision received July 29, 2010
Accepted August 25, 2010
Published first September 13, 2010.
Previous version (September 13, 2010 - 08:22).
Torsten O. Nielsen1,
Joel S. Parker2,
Samuel Leung1,
David Voduc1,
Mark Ebbert3,
Tammi Vickery4,
Sherri R. Davies5,
Jacqueline Snider5,
Inge J. Stijleman3,
Jerry Reed4,
Maggie C.U. Cheang1,2,
Elaine R. Mardis4,6,
Charles M. Perou2,
Philip S. Bernard3, and
Matthew J. Ellis5,6
Authors' Affiliations: 1Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, British Columbia, Canada; 2Lineberger Comprehensive Cancer Center and Departments of Genetics, and Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah; and 4Department of Genetics, The Genome Center, Washington University School of Medicine, St Louis, Missouri; 5Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, Missouri; 6Siteman Comprehensive Cancer Center, Washington University School of Medicine and Barnes-Jewish Hospital, St Louis, Missouri
Torsten O. Nielsen, Department of Pathology and Laboratory Medicine, University of British Columbia, Anatomical Pathology JP1401, Vancouver Hospital, 855 West 12th Avenue, Vancouver, British Columbia, Canada V5Z 1M9. Phone: 604-875-4111-66768; Fax: 604-875-4797; E-mail: torsten{at}interchange.ubc.ca.
You are going to email the following A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Clin Cancer Res November 1 2010 (16) (21) 5222-5232; DOI: 10.1158/1078-0432.CCR-10-1282
18FDG PET-MRI of Breast Tumors: Feasibility
TP53 in Breast Cancer
FDOPA PET Survival Predictions for Glioma
Show more Imaging, Diagnosis, Prognosis